Elucidating the Role of Molecular Signaling Pathways in the Tumorigenesis of Basal Cell Carcinoma

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 4 SUPPL., 2011, Pages

  Tang, Jean Y ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Basal cell carcinoma; Gorlin syndrome; Hedgehog signaling pathway; Patched 1 gene mutation; Pathogenesis

Indexed keywords

PROTEIN PATCHED 1; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SONIC HEDGEHOG PROTEIN; VISMODEGIB;

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CARCINOGENESIS; GENE MUTATION; GENE TARGETING; HAIR FOLLICLE; HUMAN; NONHUMAN; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPINA BIFIDA;

ANILIDES; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; CELL TRANSFORMATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; PYRIDINES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 83655193545     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.11.001     Document Type: Article

References (28)

1. Rubin A.I., Chen E.H., Ratner D. Basal-cell carcinoma. N Engl J Med 2005, 353:2262-2269.
2. Karagas M.R., Stannard V.A., Mott L.A., et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002, 94:224-226.
3. Cleaver J.E., Crowley E. UV damage, DNA repair and skin carcinogenesis. Front Biosci 2002, 7:d1024-d1043.
4. Gailani M.R., Leffell D.J., Ziegler A., et al. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst 1996, 88:349-354.
5. van Dam R.M., Huang Z., Rimm E.B., et al. Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol 1999, 150:459-468.
6. Naldi L., DiLandro A., D'Avanzo B., et al. Host-related and environmental risk factors for cutaneous basal cell carcinoma: Evidence from an Italian case-control study. J Am Acad Dermatol 2000, 42:446-452.
7. Nusslein-Volhard C., Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287:795-801.
8. Peifer M., Bejsovec A. Knowing your neighbors: Cell interactions determine intersegmental patterning in Drosophila. Trends Genet 1992, 8:242-248.
9. Hooper J.E., Scott M.P. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005, 6:306-317.
10. Tang J.Y., So P.-L., Epstein E.H. Novel Hedgehog pathway targets against basal cell carcinoma. Toxicol Appl Pharmacol 2007, 224:257-264.
11. Chuang P.-T., McMahon A.P. Vertebrate Hedgehog signaling modulated by induction of a Hedgehog-binding protein. Nature 1999, 397:617-621.
12. Kogerman P., Grimm T., Kogerman L., et al. Mammalian Suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol 1999, 1:312-319.
13. Incardona J.P., Roelink H. The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly. Cell Mol Life Sci 2000, 57:1709-1719.
14. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001, 15:3059-3087.
15. Quinn A.G., Epstein E. Patched, hedgehog, and skin cancer. Methods Mol Biol 2003, 222:85-95.
16. Farndon P.A., Del Mastro R.G., Evans D.G.R., et al. Location of gene for Gorlin syndrome. Lancet 1992, 339:581-582.
17. Shanley S., Ratcliffe J., Hockey A., et al. Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals. Am J Med Genet 1994, 50:282-290.
18. Lo Muzio L., Nocini P.F., Savoia A., et al. Nevoid basal cell carcinoma syndrome: Clinical findings in 37 Italian affected individuals. Clin Genet 1999, 55:34-40.
19. Ahn S.G., Lim Y.S., Kim D.K., et al. Nevoid basal cell carcinoma syndrome: A retrospective analysis of 33 affected Korean individuals. Int J Oral Maxillofac Surg 2004, 33:458-462.
20. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008, 3:32-48.
21. Johnson R., Rothman A., Xie J., et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996, 272:1668-1671.
22. Bodak N., Queille S., Avril M.F., et al. High levels of patched gene mutations in basal cell carcinomas in patients with xeroderma pigmentosum. Proc Natl Acad Sci U S A 1999, 96:5117-5122.
23. Von Hoff D.D., LoRusso P.M., Rudin C.M., et al. Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172.
24. Rubin L.L., de Sauvage F.J. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006, 5:1026-1033.
25. Chen J.K., Taipale J., Cooper M.K., et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002, 16:2743-2748.
26. Rudin C.M., Hann C.L., Laterra J., et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009, 361:1173-1178.
27. Genentech submits new drug application to FDA for vismodegib for rare form of advanced skin cancer Accessed November 1, 2011. http://www.biotechnologyevents.com/node/4534.
28. Tang J.Y., Mackay-Wiggan J.M., Aszterbaum M., et al. An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients. Presented at: 69th Annual Meeting of the American Academy of Dermatology February 4-8, 2011.